Education
About Us
Working with TipRanks
Follow Us
Organigram Global (TSE:OGI)
TSX:OGI
OGI Stock Chart & Stats
C$1.96
-C$0.12(-4.94%)
At close: 4:00 PM EST
C$1.96
-C$0.12(-4.94%)
Day’s Range― - ―
52-Week RangeC$1.22 - C$3.09
Previous CloseN/A
Volume112.96K
Average Volume (3M)273.09K
Market Cap
C$254.06M
Enterprise ValueC$265.74M
Total Cash (Recent Filing)C$8.38M
Total Debt (Recent Filing)C$8.45M
Price to Earnings (P/E)13.5
Beta2.22
Next Earnings
Apr 14, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.14
Shares Outstanding135,135,990
10 Day Avg. Volume393,556
30 Day Avg. Volume273,086
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)1.03
Price to Sales (P/S)1.39
P/FCF Ratio-14.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$3.68Price Target Upside87.80% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)0.15
Revenue Forecast (FY)C$313.53M
Bulls Say, Bears Say
Bulls Say
European ExpansionAcquisition of Sanity Group establishes a German presence and creates a platform to expand into broader European markets, enabling access to higher-margin flower sales in the UK and Poland.
Margin ResilienceAdjusted gross margin expanded sequentially and gross margins held broadly in line with expectations, suggesting operational resilience that could support improved profitability as volumes scale.
Scale And DistributionAcquisitions such as Motif broaden sales channels and add scale, supporting diversified distribution that can drive revenue growth across domestic and international markets.
Bears Say
Balance Sheet And DilutionTransaction requires cash and issuance of shares, which may strain the balance sheet and dilute existing shareholders, weighing on investor sentiment.
Demand-driven Revenue WeaknessNet revenue missed expectations amid softer domestic adult-use demand and weaker international sales, raising concerns about near-term top-line momentum.
Operational Disruptions And QualityOperational disruptions and product quality issues constrained international shipments and intensified competitive pressure, potentially hindering market share recovery.
Organigram Global News
OGI FAQ
What was Organigram Global’s price range in the past 12 months?
Organigram Global lowest stock price was C$1.22 and its highest was C$3.09 in the past 12 months.
What is Organigram Global’s market cap?
Organigram Global’s market cap is C$254.06M.
When is Organigram Global’s upcoming earnings report date?
Organigram Global’s upcoming earnings report date is Apr 14, 2026 which is in 50 days.
How were Organigram Global’s earnings last quarter?
Organigram Global released its earnings results on Feb 10, 2026. The company reported C$0.143 earnings per share for the quarter, beating the consensus estimate of -C$0.01 by C$0.153.
Is Organigram Global overvalued?
According to Wall Street analysts Organigram Global’s price is currently Undervalued.
Does Organigram Global pay dividends?
Organigram Global does not currently pay dividends.
What is Organigram Global’s EPS estimate?
Organigram Global’s EPS estimate is -0.01.
How many shares outstanding does Organigram Global have?
Organigram Global has 135,135,990 shares outstanding.
What happened to Organigram Global’s price movement after its last earnings report?
Organigram Global reported an EPS of C$0.143 in its last earnings report, beating expectations of -C$0.01. Following the earnings report the stock price went down -12.903%.
Which hedge fund is a major shareholder of Organigram Global?
Currently, no hedge funds are holding shares in TSE:OGI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Organigram Global Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$3.68 (87.80% Upside)
C$3.68 (87.80% Upside)
Blogger Sentiment
Bullish
TSE:OGI Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $19.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 13.4%
Last 30 Days ▲ 4.5%
Last 30 Days ▲ 4.5%
News Sentiment
Very Bullish
Bullish news 83%
Bearish news 17%
Bearish news 17%
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.62%
12-Months-Change
Fundamentals
Return on Equity
4.77%
Trailing 12-Months
Asset Growth
16.19%
Trailing 12-Months
Company Description
Organigram Global
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
OGI Company Deck
OGI Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
Organigram reported a strong quarter with record-breaking revenue and significant market share in Canada, supported by international expansion and operational improvements. However, challenges with ERP integration and delays in EU GMP certification presented some setbacks. Despite these challenges, the company's positive cash flow and strategic initiatives suggest a strong long-term trajectory.View all TSE:OGI earnings summariesOGI Stock 12 Month Forecast
Average Price Target
C$3.68
▲(87.80% Upside)
Technical Analysis
Canopy Growth
―
Aurora Cannabis
―
Cronos Group
―
Curaleaf Holdings
―
Green Thumb Industries
―
Options Prices
Currently, No data available
---